mTOR (mammalian target of rapamycin) signalling and macroautophagy (henceforth autophagy) regulate numerous pathological and physiological processes, including cellular responses to altered nutrient levels. However, the mechanisms regulating mTOR and autophagy remain incompletely understood. Lysosomes are dynamic intracellular organelles 1,2 intimately involved both in the activation of mTOR complex 1 (mTORC1) signalling and in degrading autophagic substrates 3-8 . Here we report that lysosomal positioning coordinates anabolic and catabolic responses with changes in nutrient availability by orchestrating early plasma-membrane signalling events, mTORC1 signalling and autophagy. Activation of mTORC1 by nutrients correlates with its presence on peripheral lysosomes that are physically close to the upstream signalling modules, whereas starvation causes perinuclear clustering of lysosomes, driven by changes in intracellular pH. Lysosomal positioning regulates mTORC1 signalling, which in turn influences autophagosome formation. Lysosome positioning also influences autophagosome-lysosome fusion rates, and thus controls autophagic flux by acting at both the initiation and termination stages of the process. Our findings provide a physiological role for the dynamic state of lysosomal positioning in cells as a coordinator of mTORC1 signalling with autophagic flux.
sclerosis complex (TSC1/2) and the Ras-family GTP-binding protein Ras homologue enriched in brain (Rheb). This occurs through different upstream pathways, including phosphatidylinositol-3-OH kinase (PI(3)K) and protein kinase B (PKB/Akt; refs 9-12) . The mechanisms by which amino acids regulate mTOR activity are less well understood, but Rag GTPases and the Ragulator complex can mediate this response by enhancing the association of mTORC1 with the late endosomal/lysosomal compartment by bringing mTORC1 close to its activator Rheb (refs 3,4,13) . mTORC1 activation stimulates protein synthesis through its phosphorylation substrates p70-S6 kinase (S6K) and eukaryotic translation initiation factor 4E-binding protein [10] [11] [12] . Conversely, starvation inactivates mTORC1, thereby inhibiting anabolic processes and liberating nutrient reserves by activating autophagy. In autophagy, cytoplasmic proteins, protein complexes and organelles are engulfed by double-membrane vesicles called autophagosomes, which are transported along microtubules towards their minus-ends and ultimately fuse with lysosomes, where their contents are degraded 5, 6, 8 . Thus, lysosomes are intimately involved in nutrient responses, as they are a site for mTORC1 activation and a sink for autophagy.
Nutrient deprivation has been reported to release mTOR from lysosomes, whereas amino-acid replenishment restores lysosomal localization of mTOR and its activity 3, 4 . We extended these observations using three different starvation protocols (see Methods). Complete nutrient deprivation, as described previously 3, 4 , decreased co-localization between mTOR and the late endosomal/lysosomal markers lysosome-associated membrane protein 1 (LAMP1) or LAMP2, and inhibited mTOR activity, as assayed by the phosphorylation status of S6K at an mTOR-specific phosphorylation site (Supplementary Fig. S1a -c, data not shown). However, milder (but more physiological) starvation protocols enabled retention of mTOR on lysosomes without preventing a loss of mTOR activity (Fig. 1a,b and Supplementary Fig. S7 . Supplementary Fig. S1d-i) . However, the intracellular distribution of lysosomes and lysosome-associated mTOR correlated with nutritional status and mTOR activity. All three starvation protocols increased the proportion of cells with predominantly perinuclear lysosomes, whereas on recovery (replenishment of amino acids either alone or together with serum) mTOR activity restoration was paralleled by the increased localization of LAMP1-and mTOR-positive vesicles at the cell periphery, including plasma-membrane projections, such as lamellipodia (Fig. 1a-c and Supplementary Fig. S1a -l). As previously described 3, 4 , mTORC1, rather than mTORC2, associates with lysosomes, because LAMP1-positive vesicles co-localized with the mTORC1 complex-specific subunit raptor, but not with mTORC2-specific rictor ( Supplementary Fig. S2a,b) . We investigated if the correlation between mTORC1 activity and lysosomal positioning is an epiphenomenon, or if they are causally linked. First, we tested whether changes in the localization of LAMP1-positive vesicles could be a consequence of altered mTOR activity. However, neither inhibition of mTOR signalling by raptor or rictor short interfering RNA (siRNA) knockdown or with its specific inhibitor rapamycin, nor upregulation of mTORC1 activity by overexpression of mTOR, raptor or Rheb, affected the positioning of LAMP1-positive vesicles (Supplementary Therefore, we considered an alternative possibility that lysosomal positioning influenced mTORC1 activity, because the peripheral localization of lysosomal mTORC1 would bring it closer to upstream signalling molecules at the cell membrane, such as the active form of Akt, of which a major pool was detected close to the plasma membrane during the recovery phase (it is inactive during starvation; Fig. 1d ; refs 14,15) . Accordingly, we investigated whether factors that alter lysosomal positioning, independent of changes in nutrient availability, affected mTORC1 activity. Short-term treatment with the microtubuledepolymerizing drug nocodazole dispersed lysosomes uniformly in the cell and obliterated any differences in lysosomal positioning seen during our starvation-recovery treatments ( Fig. 2a ). Nocodazole tended to suppress mTORC1 activity under basal conditions in full tissue-culture medium and prevented the full recovery of mTORC1 signalling on restoration of nutrients after starvation ( Fig. 2b ).
We tested our hypothesis using more specific tools by overexpressing two kinesin superfamily members, KIF1Bβ and KIF2, which redistribute lysosomes to the cell periphery 16, 17 . The kinesin-induced increase in the peripheral localization of LAMP1-and mTOR-positive compartments correlated with increased mTORC1 activity ( Fig. 2c-e ). The small GTPase ADP-ribosylation factor-like 8B (ARL8B, also called Gie2) localizes to lysosomes and also distributes them to the periphery [18] [19] [20] . We confirmed these data and found that overexpression of ARL8B, similarly to the kinesins, increased localization of lysosomal mTORC1 at the cell periphery and enhanced its activity ( Fig. 2c-e and Supplementary Fig. S3a ). We also tested the converse situation by knocking down KIF2 and ARL8B and found that it resulted in clustering of lysosomes around the microtubule-organizing centre (MTOC), which correlated with reduced mTORC1 activity ( Fig. 2c-e ). Shortterm nocodazole treatment obliterated any differences in lysosomal localization caused by ARL8B, and also flattened any differential effects of ARL8B knockdown or overexpression ( Supplementary Fig. S3b ). Thus, the effects of ARL8B on mTORC1 activity are unlikely to be due Actin - to a direct interaction of ARL8B with mTORC1, but are microtubule dependent and correlate with lysosomal localization, consistent with mTORC1 activity being regulated by lysosomal positioning. Forcing lysosomes to the cell periphery by ARL8B overexpression, or inducing their perinuclear clustering by ARL8B or KIF2 knockdown, prevented the changes in lysosomal distribution that normally occur during starvation-recovery phases ( Fig. 3a,b ). This enabled us to test whether appropriate lysosomal positioning is required for the changes in mTORC1 signalling during starvation-recovery. During starvation, no mTORC1 activity was detected (assessed by S6K phosphorylation), even when lysosomes remained peripheral owing to ARL8B overexpression, indicating that peripheral localization of lysosomes and of lysosomal mTOR is not sufficient for mTORC1 signalling in the absence of upstream signalling induced by nutrients ( Fig. 3a-c) . However, the predominantly peripheral lysosomal localization mediated by ARL8B overexpression enhanced the induction of mTORC1 signalling on addition of nutrients after starvation, whereas preventing lysosomal spreading by ARL8B or KIF2 knockdown reduced the restoration of mTOR signalling in the recovery period ( Fig. 3a-c) . Therefore, lysosomal distribution seems to modulate the intensity of mTORC1 signalling response to nutrients.
To investigate mechanisms responsible for changes in lysosomal localization in response to nutrients, we tested whether our starvation-recovery protocols affected intracellular pH (pH i ), which controls lysosomal positioning 1 . All three starvation protocols increased pH i from ∼7.1 to ∼7.7, returning to basal levels after nutrient restoration ( Fig. 4a ). Such pH i alterations were sufficient to affect lysosomal positioning and mTORC1 activity in full tissue-culture medium ( Fig. 4b-d ). Importantly, changing lysosomal positioning by manipulating ARL8B or KIF2 levels did not affect pH i (Fig. 4e ). These results indicate that nutrient levels control pH i , which changes lysosomal localization, thus affecting mTOR signalling.
We speculated that nutrients and pH i may influence lysosomal movement by affecting binding of proteins such as KIF2 or ARL8B to lysosomes or microtubules. Both nutrient deprivation and increased pH i reduced the levels of these proteins in lysosomal fractions, whereas restoration of nutrients or basal pH i fully or partially reversed this phenotype (Fig. 4f ,g). However, starvation and high pH i do not seem to decrease the ability of KIF2 and ARL8B to move lysosomes by reducing their binding to polymerized microtubules ( Fig. 4h ,i). Thus, nutrients may stimulate lysosomal redistribution to the cell periphery by maintaining lower pH i , which favours recruitment to lysosomes of proteins that control their intracellular positioning, whereas starvation increases pH i and displaces these proteins from lysosomes.
By influencing mTORC1 activity, lysosomal positioning would be anticipated to regulate autophagosome formation. Perinuclear positioning of lysosomes should also favour autophagosome-lysosome fusion by placing more lysosomes in the travel path of autophagosomes that form randomly in cells and move along microtubules towards the MTOC (ref. 5). Thus, lysosomal positioning may coordinate autophagic flux at both the initiation and termination stages ( Fig. 5a ). This would be consistent with observations that starvation, while increasing autolysosome formation (detected as an increase in the proportion of green fluorescent protein (GFP)-quenched, monomeric red fluorescent protein (mRFP)-only microtubule-associated protein 1 light chain 3 (LC3)-positive dots in cells stably expressing mRFP-GFP tandem fluorescent-tagged LC3 (tfLC3; ref. 21)), can, in some cells, reduce the steady-state numbers of autophagosomes (which correlate with the levels of the lipidated, autophagosome-associated form of LC3; LC3-II; ref. 22) , indicating that starvation is simultaneously increasing the rates of autophagosome/LC3-II formation and degradation ( Fig. 5b and Supplementary Fig. S4a-c) . Accordingly, we investigated whether autophagic flux is affected by factors that modulate lysosomal distribution, focusing on ARL8B, which had the strongest effect on lysosomal positioning and mTORC1 activity. We measured steady-state autophagosome/LC3-II levels as well as autophagosome formation (levels of LC3-II in the presence of lysosomal inhibitor bafilomycin A1 that blocks its degradation) 22 . In line with our prediction (Fig. 5a ), ARL8B knockdown increased autophagosome formation (LC3-II levels in the presence of bafilomycin A1) ( Fig. 5c ), consistent with the decreased mTOR activity ( Fig. 2e ). ARL8B knockdown in nutrient starvation conditions, when mTOR activity is suppressed, had no significant effect on autophagosome formation ( Supplementary Fig. S4d ). ARL8A, a close homologue of ARL8B, phenocopies ARL8B and the two proteins have additive effects on autophagy ( Supplementary  Fig. S4e ,f). These ARL8 effects were confirmed using different sets of SMARTpool siRNA as well as individual siRNA oligonucleotides ( Supplementary Fig. S4e-j) . Similarly to ARL8A/B, knockdown of KIF2, which increased lysosomal perinuclear localization and reduced mTORC1 activity ( Fig. 2c-e ), also increased autophagosome synthesis ( Supplementary Fig. S4k -n). Lysosomal scattering induced by ARL8B overexpression increased steady-state LC3-II levels and numbers of autophagic vesicles. However, in the presence of bafilomycin A1, LC3-II levels were either unaffected or even reduced ( Fig. 5d and Supplementary Fig. S5a-e ). Thus, ARL8B may reduce autophagosome formation (LC3-II in the presence of bafilomycin A1), as well as autophagosome-lysosome fusion (increased LC3-II in normal medium). KIF2A overexpression mimicked this effect on LC3-II levels, although its effect was less pronounced ( Supplementary Fig. S5a-e ). We could rescue the effects of ARL8B and KIF2A overexpression by a simultaneous knockdown of the relevant proteins demonstrating siRNA specificity ( Supplementary Fig. S5a-e ). As previously seen for ARL8A knockdown, its overexpression phenocopied the effect of ARL8B overexpression on LC3-II levels ( Supplementary Fig. S5f ).
To further test that lysosomal positioning could influence autophagosome-lysosome fusion, we measured the effect of ARL8B on the proportion of autophagosomes (marked with mCherry-LC3) that co-localizes with lysosomes (marked with anti-LAMP1 antibody or with lgp120-eGFP, a lysosomal membrane glycoprotein with a relative molecular mass (M r ) of 120K fused to enhanced green fluorescent protein). As predicted ( Fig. 5a ), overexpression of ARL8B decreased autophagosome-lysosome co-localization ( Fig. 5e,f and Supplementary Fig. S5g,h) . This autophagosome-lysosome fusion defect was not due to decreased lysosome numbers, as ARL8B overexpression did not change the expression of LAMP1, LAMP2 or mature cathepsin D ( Supplementary Fig. S5i ). The effect of ARL8B overexpression on autophagosome-lysosome fusion is also not due to increased mTOR activity and decreased autophagosome synthesis. First, ARL8B overexpression increased total autophagosome numbers despite decreasing autophagosome formation ( Fig. 5d ), indicative of a block at the fusion step. Second, ARL8B overexpression resulted in an increase in autophagosome/LC3-II levels, even when mTORC1 activity was blocked by rapamycin ( Supplementary Fig.  S5j ). Indeed, the ability of rapamycin to reduce the accumulation of mutant huntingtin, an autophagy substrate, was blocked by ARL8B overexpression ( Supplementary Fig. S5k ). Finally, ARL8B inhibited autophagosome-lysosome fusion in a kinesin-and microtubuledependent manner ( Supplementary Fig. S5l-n) .
Conversely, knockdown of ARL8B enhanced autophagosome-lysosome co-localization ( Fig. 5e,f) , whereas simultaneous knockdown of ARL8B and ARL8A additively enhanced autophagosome-lysosome fusion (Fig. 5g ). This reflects increased autophagosome-lysosome fusion and not simply increased proximity in a tight perinuclear cluster, because increased co-localization was also observed after the lysosomal cluster was scattered throughout the cytoplasm by subsequent nocodazole treatment (Fig. 5h ). The effects of ARL8B on autophagosome-lysosome fusion were also confirmed in tfLC3-expressing cells ( Fig. 5i and Supplementary Fig. S5o ).
To test the potential physiological and clinical relevance of our results we investigated the effects of ARL8 and KIF2 overexpression and knockdown on autophagic flux using diverse autophagic substrates. These include mutant forms of huntingtin associated with Huntington's disease (eGFP-httQ74; ref. 23 ), mutant A53T α-synuclein that causes some familial forms of Parkinson's disease (eGFP-A53T; ref. 24 ) and
Mycobacterium tuberculosis var. bovis Bacillus Calmette-Guérin (BCG), which is related to the tuberculosis-causing mycobacterium 25, 26 . ARL8 or KIF2 knockdowns had protective effects in these disease models by reducing the levels of pathogenic autophagic substrates, whereas overexpression had the opposite effects ( Supplementary Fig. S6a -n). In agreement with its role in mTOR signalling and autophagy, knockdown of the Drosophila ARL8 homologue reduced S6K phosphorylation and suppressed polyglutamine toxicity in vivo ( Supplementary Fig. S6o,p) .
In summary, lysosomes change their intracellular positioning in response to nutrient availability, thus coordinating mTORC1 activity, autophagosome synthesis and autophagosome-lysosome fusion. During starvation, mTORC1 activity is repressed, which induces autophagosome formation. Starvation increases pH i , causing lysosomes to cluster near the MTOC, facilitating autophagosome-lysosome fusion. This may be due to a pH-dependent loss of proteins regulating anterograde lysosome movement from lysosomes. Conversely, nutrient replenishment restores basal pH i inducing lysosomal scattering, which brings lysosomal mTORC1 to the cell periphery and stimulates its activity by increasing its coupling to the gradient of signalling molecules emanating from the plasma membrane 14, 15 . The intracellular gradient of active Akt, as reported here, is consistent with previous observations, for example the localization and activation of Akt at the leading edge of chemotaxing cells 27 .
Our data are consistent with multiple independent mechanisms regulating mTORC1 signalling 3, 4, 10, 11, 13 . The lysosomal association of mTORC1 is required for its activation by amino acids, but constitutive targeting of mTORC1 to lysosomes does not completely abolish its sensitivity to amino acids, indicative of other mechanisms of regulation 3 . Although lysosomal redistribution during the recovery phase after starvation may not be the initial or sole trigger for mTOR activation, lysosomal localization enables another level of control that modulates and reinforces other signalling inputs to mTOR.
Although most known autophagy-inducing signals affect autophagosome synthesis, here we show that the archetypical signal, starvation, impacts at both the synthesis and autophagosome-lysosome fusion stages, which would greatly increase the efficiency of the delivery of autophagic substrates for catabolism, compared with just increasing autophagosome synthesis. This will enhance autophagy-mediated nutrient release during starvation, facilitating the rapid availability of secondary energy sources and, therefore, cell survival. This may be an adaptation that has particular advantages in higher eukaryotic cells, where autophagosomes are generally formed at sites that are distant from lysosomes, whereas yeast autophagosomes originate close to the vacuole.
Finally, autophagy is increasingly recognized as being a central cellular process for a wide variety of human diseases, including cancer, neurodegeneration and infectious diseases. In this context, our findings may have therapeutic potential, because ARL8 proteins are GTPases and thus provide potential drug targets. For example, increased mTORC1 activity and decreased autophagy are associated with tumorigenesis, and lysosomal spreading is associated with metastasis 28 . Our data indicate that all of these phenomena may be targeted by ARL8 inhibition. Furthermore, because suppression of ARL8 activity increased the clearance of a wide range of disease-associated autophagic substrates, ARL8 inhibition may provide a tractable therapeutic target for various infectious and neurodegenerative diseases. Wild-type ARL8A-Flag, wild-type ARL8B-Flag and ARL8B Q75L (ARL8B-CA)-Flag vectors were derived by inserting ARL8A or ARL8B complementary DNA into pCMV5a containing the carboxy-terminal Flag tag (Sigma) using SalI and KpnI. ARL8B fused to cyan fluorescent protein (CFP) was obtained by cloning ARL8B cDNA into pECFP-N1 (Clontech) using XhoI and BamHI. To generate mCherry-LC3, the mCherry DNA was amplified using pRSET-B as a template using the following primers: 5 -TA CCG AGC TCG GTA CCC GCC ACC AT-3 and 3 -G CTG TAC AAG GAA GGA TCC TGC-5 . The resulting fragment was inserted into the 5 end of hLC3B in pcDNA3 (Invitrogen). All restriction endonucleases were purchased from New England BioLabs. siRNA. ON-TARGETplus SMARTpool siRNA against human ARL8B (J-020294-09 or L-020294-01), mouse ARL8B (J-056525-09), human ARL8A (L-016577-01), human KIF2A (L-004959-00), human raptor (L-004107-00), human rictor (L-016984-00), human Akt1 (L-003000-00), non-targeting SMARTpool siRNA (D-001810-04) and individual oligonucleotides of siRNA against human ARL8B (LQ-020294-01-0002) and KIF2 (LQ-004959-00-0002) were purchased from Dharmacon. An alternative set of Stealth/siRNA duplex oligonucleotides against ARL8B (127338D10) and ARL8A (127338D09) was purchased from Invitrogen. The ARL8B siRNAs do not match sequences in ARL8A and vice versa. Final siRNA concentrations of 50 or 100 nM were used for silencing.
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Starvation and recovery protocols. Three starvation protocols were used. Protocol 1 was complete nutrient deprivation. HeLa cells grown in wells of six-well plates were washed briefly in 2 ml of Hanks Balanced Salt Solution (Sigma H9394 or GIBCO 14025), media aspirated, and 2 ml of fresh Hanks Balanced Salt Solution was added followed by 45 min incubation at 37 • C. Protocol 2 was milder serum and amino-acid starvation. Full tissue-culture medium in six-well plates was aspirated, 2 ml of Hanks Balanced Salt Solution was added and incubated at 37 • C for 5 h. Protocol 3 was serum starvation. Cells in wells of six-well plates were washed briefly in 2 ml of serum-free DMEM (containing ×1 amino acids, Sigma D6546), media aspirated, and 2 ml of fresh serum-free DMEM was added followed by 24 h incubation at 37 • C. Recovery after starvation was achieved by addition of 2 ml DMEM with extra ×1 amino acids (MEM amino acids ×50 liquid, GIBCO 11130051, and l-glutamine, Sigma G7513) with or without 5% FBS (Sigma, F7524) at pH 7.2. For experiments in 24-well plates, volumes of the media were reduced to 0.5 ml per well.
Immunoblotting. The procedure has been described before 38 . The following primary antibodies were used in this study: anti-human ARL8 that recognizes both ARL8A and ARL8B (1:1,000; ref. 20) , anti-ARL8B (ProteinTech Group, 1:1,000), anti-KIF2 (Abnova, 1:1,000), anti-GFP (Clontech, 1:2,000), anti-actin (1:2,000), anti-tubulin (1:2,000), anti-Flag (1:1,000), anti-HA (Covance, 1:1,000), anti-LC3 (Novus Biologicals, 1:2,000), anti-Atg5 (Novus Biologicals, 1:1,000), anti-S6 ribosomal protein (Cell Signaling, 1:1,000), anti-phospho-S6 ribosomal protein (Ser 235/236; Cell Signaling, 1:1,000), anti-p70 S6K (Cell Signaling, 1:1,000), anti-phospho-p70 S6K (Thr 389) (Cell Signaling, 1:1,000), anti-Bcl-2 (Cell Signaling, 1:1,000), anti-phospho-Bcl-2 (Ser 70; Cell Signaling, 1:1,000), anti-cathepsin D (Abcam, 1:1,000), anti-LAMP1 (Developmental Studies Hybridoma Bank, 1:500), anti-LAMP2 (Developmental Studies Hybridoma Bank, 1:500), anti-raptor (Origene, 1:500), anti-rictor (Bethyl Laboratories, 1:1,000), anti-Akt (Cell Signaling, 1:1,000), anti-Drosophila ARL8 antibody (1:1,000; ref. 19 ) and anti-phospho-Drosophila p70 S6K (Thr 398) antibody (Cell Signaling, 1:1,000). Secondary antibodies were either horse radish peroxidase (HRP) conjugated (Roche, 1:5,000) and the signal was detected by autoradiography using an enhanced chemiluminescence western blotting kit (GE Healthcare) or conjugated to IRDye for detection at 780 or 680 nm (Li-Cor Biosciences) and visualized and quantified using an Odyssey imaging system (Li-Cor Biosciences).
Immunofluorescence. The procedure for immunofluorescence, cell death and aggregate count has been described before 38 . The following primary antibodies were used in this study: anti-human ARL8 that recognizes both ARL8A and ARL8B (1:100), anti-HA antibody (Covance, 1:500), anti-Flag (1:500), anti-LAMP1, anti-LAMP2 and anti-CD63 (Developmental Studies Hybridoma Bank, 1:1,000), anti-LC3 (NanoTools, 1:500), anti-mTOR (Cell Signaling, 1:200), anti-phospho-mTOR (Ser2448) (Cell Signaling, 1:100), anti-phospho-Akt (S308) (Cell Signaling, 1:100), anti-raptor (Origene, 1:50) or anti-rictor (Bethyl Laboratories, 1:200).
Co-localization measurements. The Colocalization plugin in ImageJ (NIH) was applied to measure co-localization between two channels of confocal z stacks (a constant threshold for all of the images within each experiment was applied). A maximum-intensity projection was generated and the area of co-localizing pixels (including objects of three pixels and above) was quantified using the Analyse Particles plugin in ImageJ and expressed as the total area of co-localization per cell. Quantification was carried out on at least 20 cells per condition from two to four independent experiments.
To measure co-localization between mCherry-LC3 vesicles and lysosomes, cells were co-transfected with plasmid DNA and siRNA against proteins of interest together with mCherry-LC3 (and for some experiments with lgp120-eGFP). In some experiments, cells were immunostained using mouse monoclonal LAMP1 antibody. The percentage of mCherry-LC3 vesicles co-localizing with late endosomes/lysosomes (LAMP1 or lgp120-eGFP positive) to the total number of mCherry-LC3 vesicles was calculated from stacks of confocal images through the whole thickness of the cell using ImageJ (NIH) or Volocity (Improvision). All of the values were normalized to the control.
Quantification of lysosomal distribution.
To score lysosomal distribution, cells were categorized into perinuclear-dominant lysosomal pattern (more than 50% of LAMP1-or lgp120-eGFP-positive vesicles localized in the perinuclear region) and peripheral-dominant pattern (more than 50% of the vesicles localized in the peripheral region), on the basis of the number of lysosomes in each region. Quantification is based on at least three independent experiments, each carried out in triplicate, and 100-200 cells were counted in each slide; the scorer was blinded to treatment. The data are expressed as a proportion of cells with predominantly (>50%) peripheral lysosomes.
Measurement and manipulation of pH i . pH i was determined using pH-sensitive fluorescent dye 2 7 -bis-(2-carboxyethyl)-5-(and-6)carboxyfluorescein-acetoxymethyl (Invitrogen) as described 39 . Fluorescence was measured with Cytofluor Multiplate reader (PerSeptive Biosystems) or Multilabel reader EnVision 2103 (Perkin Elmer). Two fluorescence measurements were made at (1) an excitation wavelength (λ ex ) of 485 nm and an emission wavelength (λ em ) of 530 nm and (2) a λ ex of 450 nm and a λ em of 530 nm; the fluorescence ratio (1)/(2) was used to calculate pH i . To change pH i , cells were incubated for 50 min at 37 • C in full tissue-culture medium that contained nigericin, which enables changes in pH i to be forced by altering the pH in the medium. When the pH of the medium was adjusted to 6.5 and 8, the pH i changed (from 7.2 under normal conditions) to 7.1 and 7.7-7.8, respectively, as determined by the calibration curve.
Lysosome-and microtubule-isolation protocols.
Lysosomes were isolated with the Lysosome Enrichment Kit for Tissue and Cultured Cells (Thermo Scientific) according to the manufacturer's instructions. Isolation of polymeric microtubules was carried out using the centrifugation method as previously described 40 .
Autophagy analyses. Measuring the levels of endogenous LC3-II/actin ratios as a readout for autophagosome numbers has been previously described 41 . To quantify endogenous LC3-positive vesicles, cells were immunolabelled using anti-LC3 antibody (NanoTools). Slides were scored for a percentage of cells with more than 20 LC3-positive vesicles. All experiments were carried out DOI: 10.1038/ncb2204 in triplicate with at least 200 cells counted per slide; the scorer was blinded to treatment.
Automated microscope counting of autolysosomes labelled with a pH-sensitive tfLC3 was carried out using a Thermo Scientific Cellomics ArrayScan VTI HCS reader and the Spot Detector Bioapplication protocol, version 3, as already described 41 . With tfLC3, GFP-(and RFP-) positive puncta represent autophagosomes before lysosomal fusion, whereas RFP-positive puncta (that lack GFP fluorescence) represent autolysosomes (as the GFP is more rapidly quenched by the low pH; ref. 21) . Alternatively, total areas of GFP-RFP and RFP-only positive puncta per cell were quantified from z stacks of confocal images using ImageJ and the Analyse Particles plugin (a constant threshold for all of the images within each experiment was applied). At least 20 cells per condition in three independent experiments were used for quantification.
BCG colony-forming-unit assay. After transfection by nucleoporation, cells were infected with live BCG for 1 h, washed to remove extracellular mycobacteria and incubated for 2 h in full medium or Earle's Balanced Salt Solution (starvation). Macrophages were then hypotonically lysed using cold sterile water; mycobacteria were plated on Middlebrook 7H11 agar followed by incubation at 37 • C for 2-3 weeks and colony-forming-unit counting. (d-f) HeLa cells were left untreated, starved by replacing (without wash) the nutrient-rich medium with HBSS for 5 h (protocol 2), or starved and then recovered for 45 min in the nutrient-rich medium. The starvation procedure is the same as used to obtain the data shown in Fig.1a -c of the main text. Cells were subjected to the same analyses as in panels (a-c). Note that this starvation protocol does not lead to the release of mTOR from the LAMP1positive compartment during this starvation procedure. (g-i) HeLa cells were left untreated, starved by incubating in serum-free DMEM for 24 h (protocol 3), or starved and then recovered in 5% FBS-supplemented DMEM, for 15 or 60 min. The starvation procedure is the same as used to obtain the data shown in Fig.1d of the main text. Cells were analysed as in panels (a-c).
(j-l) The quantification of changes in lysosomal positioning (expressed as a percentage of cells with predominantly peripheral lysosomes) in cells treated according to the starvation protocol 1 (j), protocol 2 (k) and protocol 3 (l). 
